Citi Pharma Limited (PSX:CPHL)
76.05
+0.32 (0.42%)
At close: Mar 11, 2026
-17.10% (1Y)
| Market Cap | 17.37B -25.6% |
| Revenue (ttm) | 14.10B +6.9% |
| Net Income | 1.04B +26.7% |
| EPS | 4.55 +26.4% |
| Shares Out | 228.46M |
| PE Ratio | 16.72 |
| Forward PE | 18.11 |
| Dividend | 3.50 (4.62%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 861,347 |
| Average Volume | 1,981,072 |
| Open | 75.89 |
| Previous Close | 75.73 |
| Day's Range | 75.25 - 78.40 |
| 52-Week Range | 60.50 - 105.31 |
| Beta | 0.42 |
| RSI | 41.58 |
| Earnings Date | Feb 13, 2026 |